Your session is about to expire
← Back to Search
Behavioural Intervention
Intervention arm - ChatGPT for Birth Control
N/A
Recruiting
Led By Premal Patel, MD
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion period, estimated to be 2 months
Awards & highlights
Study Summary
This trial aims to improve pre-vasectomy consultations by reducing time and increasing satisfaction.
Eligible Conditions
- Birth Control
- Vasectomy
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion period, estimated to be 2 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion period, estimated to be 2 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Length of Consultation
Number of questions asked
Satisfaction of patients assessed by Likert scale
Secondary outcome measures
Commonly asked questions
Incidence of inaccurate ChatGPT responses
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention arm - ChatGPTExperimental Treatment1 Intervention
Patient's interested in participating in the intervention group will be provided a secure ChatGPT account. They will have the opportunity to converse with ChatGPT to ask any potential questions they may have regarding their upcoming vasectomy. Patient's will then be seen for the standard pre-vasectomy consultation.
Group II: Control arm - no ChatGPTActive Control1 Intervention
No intervention - standard of care
Find a Location
Who is running the clinical trial?
University of ManitobaLead Sponsor
597 Previous Clinical Trials
199,392 Total Patients Enrolled
Premal Patel, MDPrincipal InvestigatorAssistant Professor, Department of Surgery. Director, Undergraduate Urologic Medical Education
1 Previous Clinical Trials
150 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger